Akebia Ther Stock Investor Sentiment

AKBA Stock  USD 2.04  0.09  4.23%   
About 66% of Akebia Ther's investor base is looking to short. The analysis of the overall investor sentiment regarding Akebia Ther suggests that many traders are alarmed. The current market sentiment, together with Akebia Ther's historical and current headlines, can help investors time the market. In addition, many technical investors use Akebia Ther stock news signals to limit their universe of possible portfolio assets.
  

Akebia Ther Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Akebia Ther can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at finance.yahoo.com         
Disposition of 8661 shares by Michel Dahan of Akebia Ther at 1.58 subject to Rule 16b-3
Yahoo News
over six months ago at www.macroaxis.com         
Disposition of 7169 shares by Steven Burke of Akebia Ther at 1.58 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 37733 shares by John Butler of Akebia Ther at 1.52 subject to Rule 16b-3
Macroaxis News
over six months ago at thelincolnianonline.com         
Acadian Asset Management LLC Sells 236,865 Shares of Akebia Therapeutics, Inc.
news
over six months ago at news.google.com         
Is Akebia Therapeutics Inc a Good Choice in Biotechnology Thursday - InvestorsObserver
Google News at Macroaxis
over six months ago at simplywall.st         
Further weakness as Akebia Therapeutics drops 12 percent this week, taking five-year losses to 80
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
Akebia Therapeutics, Inc. Short Interest Up 12.1 percent in January - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Global IV Oral Iron Drugs Market Report 2024 Market to Reach 16.43 Billion by 2029 with CSL Vifor, C...
Yahoo News
over six months ago at finance.yahoo.com         
Global IV Oral Iron Drugs Market Report 2024 Focused Insights for 2023-2029 - Increasing Prevalence ...
Yahoo News
over six months ago at finance.yahoo.com         
Acquisition by Snow Ellen of 149300 shares of Akebia Ther subject to Rule 16b-3
Yahoo News
over six months ago at finance.yahoo.com         
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over six months ago at news.google.com         
Thinking about buying stock in Alibaba Group, Akebia Therapeutics, Plug Power, AMC Entertainment, or...
Google News at Macroaxis
over six months ago at news.google.com         
Akebia Therapeutics Stock Price Passes Above 50 Day Moving Average of 1.28 - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Akebia Secures 55 Million Term Loan Financing
Yahoo News
over six months ago at seekingalpha.com         
Akebia Therapeutics closes up to 500M loan facility
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Akebia Ther that are available to investors today. That information is available publicly through Akebia media outlets and privately through word of mouth or via Akebia internal channels. However, regardless of the origin, that massive amount of Akebia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Akebia Ther news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Akebia Ther relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Akebia Ther's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Akebia Ther alpha.

Akebia Ther Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Akebia Therapeutics Inc Q2 2024 Earnings Call Highlights Strategic Advances Amid ...
10/09/2024
2
Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024
10/15/2024
3
Akebia Therapeutics Given Buy Rating at HC Wainwright
10/23/2024
4
Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights
11/01/2024
5
Acquisition by Rogers Michael W of 30000 shares of Akebia Ther subject to Rule 16b-3
11/05/2024
6
Akebia Ther earnings missed by 0.04, revenue fell short of estimates
11/07/2024
7
Earnings call Akebia reports Q3 results, gears up for Vafseo launch
11/08/2024
8
Akebia Therapeutics Downgraded to Sell Rating by StockNews.com
11/22/2024
9
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
12/03/2024

Complementary Tools for Akebia Stock analysis

When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities